Healthpeak Properties, Inc. financial data

Symbol
DOC on NYSE
Location
4600 South Syracuse Street, Suite 500, Denver, CO
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Oct 24, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Debt-to-equity 138 % +9.15%
Return On Equity -0.44 % -112%
Return On Assets -0.19 % -112%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 695M shares -0.64%
Common Stock, Shares, Outstanding 695M shares -0.64%
Entity Public Float 11.8B USD +28.3%
Common Stock, Value, Issued 695M USD -0.64%
Weighted Average Number of Shares Outstanding, Basic 695M shares -0.63%
Weighted Average Number of Shares Outstanding, Diluted 695M shares -0.75%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 2.8B USD +9.58%
Revenue from Contract with Customer, Excluding Assessed Tax 594M USD +6.33%
General and Administrative Expense 90.7M USD -4.3%
Costs and Expenses 2.62B USD +4.9%
Nonoperating Income (Expense) -29.6M USD -111%
Income Tax Expense (Benefit) -10.8M USD -265%
Net Income (Loss) Attributable to Parent -38.1M USD -112%
Earnings Per Share, Basic 0 USD/shares -109%
Earnings Per Share, Diluted 0 USD/shares -109%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 91M USD -49.5%
Operating Lease, Right-of-Use Asset 417M USD -2.42%
Intangible Assets, Net (Excluding Goodwill) 611M USD -32%
Goodwill 68.5M USD +5.17%
Assets 19.6B USD -1.94%
Liabilities 11.3B USD +5.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax -7.98M USD +35.6%
Stockholders' Equity Attributable to Parent 7.6B USD -11.3%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 8.24B USD -10.7%
Liabilities and Equity 19.6B USD -1.94%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 279M USD +83.2%
Net Cash Provided by (Used in) Financing Activities -94.4M USD -41.7%
Net Cash Provided by (Used in) Investing Activities -231M USD -136%
Common Stock, Shares Authorized 1.5B shares 0%
Common Stock, Shares, Issued 695M shares -0.64%
Common Stock, Par or Stated Value Per Share 1 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -45.7M USD -285%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 160M USD -34%
Interest Paid, Excluding Capitalized Interest, Operating Activities 80.7M USD +9.37%
Deferred Tax Assets, Valuation Allowance 2.31M USD -82.3%
Deferred Tax Assets, Gross 166M USD -3.13%
Operating Lease, Liability 301M USD -2.26%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -33.7M USD -113%
Lessee, Operating Lease, Liability, to be Paid 834M USD +53.9%
Property, Plant and Equipment, Gross 38M USD -2.56%
Lessee, Operating Lease, Liability, to be Paid, Year Two 18.4M USD +48.6%
Lessee, Operating Lease, Liability, to be Paid, Year One 21.5M USD +26.9%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure +23.6%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 527M USD +57.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 18.4M USD +49.6%
Deferred Tax Assets, Operating Loss Carryforwards 50M USD -7.56%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 18.5M USD +50.1%
Additional Paid in Capital 12.8B USD -0.62%
Deferred Tax Assets, Net of Valuation Allowance 163M USD +3.38%
Interest Expense 295M USD +12.3%